Literature DB >> 26803841

The need of a new and more physiological preclinical model for Parkinson's disease.

Juan Segura-Aguilar1, Irmgard Paris2,3, Patricia Muñoz2.   

Abstract

Entities:  

Keywords:  6-hydroxydopamine; Alpha synuclein; Aminochrome; Autophagy; Dopamine; Dopaminergic neurons; Dyskinesia; Endoplasmic reticulum stress; L-Dopa; MPTP; Mitochondria; Neurodegeneration; Neuroinflammation; Neuromelanin; Oxidation; Oxidative stress; Proteasome

Mesh：

Substances：

Year:  2016        PMID： 26803841     DOI： 10.1007/s00018-016-2140-2

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN： 1420-682X            Impact factor:   9.261


× No keyword cloud information.
  2 in total

Review 1.  New approaches to therapy.

Authors:  Jonathan Brotchie; Peter Jenner
Journal:  Int Rev Neurobiol       Date:  2011       Impact factor: 3.230

Review 2.  Protective and toxic roles of dopamine in Parkinson's disease.

Authors:  Juan Segura-Aguilar; Irmgard Paris; Patricia Muñoz; Emanuele Ferrari; Luigi Zecca; Fabio A Zucca
Journal:  J Neurochem       Date:  2014-03-18       Impact factor: 5.372
  2 in total
  7 in total

1.  Parkinson's disease: towards better preclinical models and personalized treatments.

Authors:  Dan Lindholm; Johanna Mäkelä; Valentina Di Liberto; Giuseppa Mudò; Natale Belluardo; Ove Eriksson; Mart Saarma
Journal:  Cell Mol Life Sci       Date:  2016-02-03       Impact factor: 9.261

Review 2.  Neurotoxins as Preclinical Models for Parkinson's Disease.

Authors:  Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2018-01-08       Impact factor: 3.911

3.  On the Role of DT-Diaphorase Inhibition in Aminochrome-Induced Neurotoxicity In Vivo.

Authors:  Andrea Herrera-Soto; Gabriela Díaz-Veliz; Sergio Mora; Patricia Muñoz; Pablo Henny; Harry W M Steinbusch; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2017-03-11       Impact factor: 3.911

4.  Neuroprotective effects of the gliopeptide ODN in an in vivo model of Parkinson's disease.

Authors:  Seyma Bahdoudi; Ikram Ghouili; Mansour Hmiden; Jean-Luc do Rego; Benjamin Lefranc; Jérôme Leprince; Julien Chuquet; Jean-Claude do Rego; Ann-Britt Marcher; Susanne Mandrup; Hubert Vaudry; Marie-Christine Tonon; Mohamed Amri; Olfa Masmoudi-Kouki; David Vaudry
Journal:  Cell Mol Life Sci       Date:  2017-12-20       Impact factor: 9.261

5.  Aminochrome induces dopaminergic neuronal dysfunction: a new animal model for Parkinson's disease.

Authors:  Andrea Herrera; Patricia Muñoz; Irmgard Paris; Gabriela Díaz-Veliz; Sergio Mora; Jose Inzunza; Kjell Hultenby; Cesar Cardenas; Fabián Jaña; Rita Raisman-Vozari; Katia Gysling; Jorge Abarca; Harry W M Steinbusch; Juan Segura-Aguilar
Journal:  Cell Mol Life Sci       Date:  2016-03-21       Impact factor: 9.261

6.  Protective Effects of Crude Plant Extracts against Aminochrome-induced toxicity in Human Astrocytoma Cells: Implications for Parkinson's Disease.

Authors:  Viviane L Ndam Ngoungoure; Patricia Muñoz; Yousef Tizabi; Raul Valdes; Paul Fewou Moundipa; Juan Segura-Aguilar
Journal:  Clin Pharmacol Transl Med       Date:  2019-04-08

7.  Commentary: A Humanized Clinically Calibrated Quantitative Systems Pharmacology Model for Hypokinetic Motor Symptoms in Parkinson's Disease.

Authors:  Patricia Muñoz; Juan Segura-Aguilar
Journal:  Front Pharmacol       Date:  2016-06-20       Impact factor: 5.810
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.